ASX edges up on strong energy and resources stocks
The ASX crept up less than 0.10pc in trade on Monday, wary of a lack of substance in US-China trade talks. Strength in Energy kept the bourse afloat.
Stockhead
ASR targets Leonora South gold extensions
Asra Minerals is targeting down dip extensions of the high-grade gold encountered at Leonora South.
Long Shortz: Challenger Gold
Challenger Gold signs IPA with Ecuadorean government to safeguard its investment into the El Guayabo project.
Tryptamine appoints global pharma leader as chair
Tryptamine Therapeutics has appointed global pharmaceutical leader Herwig Janssen as its new non-executive chairman.
More Stories
April’s top stocks
Australia’s S&P/ASX 200 rallied 3.62% in April, with African gallium explorer DY6 Metals winning top performing stock.
RAC doses first patient in solid tumour RC220 trial
Race Oncology has begun dosing patients in a Phase 1 clinical trial assessing RC220 in solid tumours
Is MTM’s Flash Joule tech the boost America needs?
MTM Critical Metals is aiming to help break China’s rare earths dominion with its own US-based processing solution.
Long Shortz: Pure Hydrogen
Pure Hydrogen managing director Scott Brown gives the latest from the leading US clean transport conference and unpacks the company’s plans.
Bulk Buys: Majors stay bullish on bulks, even as fears circle
Majors remain bullish about iron ore investments, even in the face of economic uncertainty in the USA and China.
Andromeda a star on 4N HPA breakthrough
Andromeda Metals has pulled off a testwork breakthrough by producing ultra-high purity 4N HPA using its own low-cost process and kaolin.
ASX lithium green shoots despite market pull-back
Although the lithium market is facing challenges, lithium resource stocks are maintaining momentum with active exploration.
ASX March winners and losers
The S&P/ASX 200 fell 3.39% in March 2025 as geopolitical impacts and impending US tariffs played on global markets.
ASX dips as US economy contracts 0.3pc
The ASX has had a wobbly start to trading, dipping marginally in the first hour as US GDP falls 0.3pc, undermined by a spike in imports.
ASX health stocks deliver March quarter progress
Some of the ASX’s most exciting health small caps rolled out their quarterly results this week, including Control Bionics, LTR Pharma, Lumos Diagnostics and EMvision Medical Devices.
Original URL: https://www.goldcoastbulletin.com.au/business/stockhead/page/24